zorevunersen Clinical Trials (2026): 2 Studies for Dravet Syndrome
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
2 zorevunersen clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 1 indication (including Dravet Syndrome) and 230 total planned enrollment. 1 Phase 3 zorevunersen trial and 1 Phase 2 are listed. 1 zorevunersen clinical trial is actively recruiting. Most recent activity: NCT04740476 (Mar 2029).
zorevunersen clinical trials at a glance: phase × recruitment status
| Phase | recruiting | active not recruiting | Total |
|---|---|---|---|
| P2 | 1 | 1 | |
| P3 | 1 | 1 |
Recruiting zorevunersen clinical trials (1)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT06872125 | A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome | P3 | Dravet Syndrome | 170 | Jun 2025 |
All zorevunersen trials (2)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT04740476 | An Open-Label Extension Study of STK-001 for Patients With Dravet Syndrome | P2 | active not recruiting | 60 | Stoke Therapeutics, Inc | Jan 2021 | |
| NCT06872125 | A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome | P3 | recruiting | 170 | Stoke Therapeutics, Inc | Jun 2025 |
zorevunersen clinical trials: frequently asked questions
- How many zorevunersen clinical trials are there?
- 2 zorevunersen clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants.
- Are zorevunersen clinical trials recruiting in 2026?
- Yes — 1 zorevunersen trial is actively recruiting in 2026. See the recruiting trials and the per-state site list further down this page.
- What conditions is zorevunersen being studied for?
- zorevunersen is being studied for Dravet Syndrome. The trials are grouped by indication on this page.
- What phase is zorevunersen in?
- zorevunersen clinical trials span 1 Phase 3, 1 Phase 2. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors zorevunersen clinical trials?
- The lead sponsor across the most zorevunersen trials is Stoke Therapeutics, Inc. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming zorevunersenas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: